HCA Healthcare, Inc. (HCA)
NYSE · Nashville, Tennessee, USA · Founded 1968 · CEO Sam Hazen
Valuation summary
$567.46 fair value versus $460.33 in the market, a difference of +23.3%. Rated Buy.
| Fair value per share | $567.46 |
| Current share price | $460.33 |
| Upside / downside | +23.3% |
| Bear case | $277.37 |
| Bull case | $991.57 |
| Discount rate (WACC) | 9.4% |
| Terminal growth | 2.60% |
| Market capitalisation | $96B |
| EV / Sales | 1.9x |
About HCA Healthcare, Inc.
Founded in 1968 in Nashville by Thomas Frist Sr., his son and Jack Massey, creating one of the first hospital chains. Sam Hazen has been CEO since 2019. HCA operates around 190 hospitals and 2,400 care sites, concentrated in fast-growing Sun Belt markets including Texas and Florida. Hospital economics depend heavily on payer mix — how many patients are commercially insured versus on Medicare, Medicaid, or uninsured.
Investment case
- Scale gives real negotiating leverage with commercial insurers and suppliers.
- Concentrated in Sun Belt markets with above-average population growth.
- Aggressive share repurchase programme has substantially reduced the share count.
Key risks
- Payer mix can deteriorate quickly if unemployment rises or subsidies lapse.
- Labour costs, particularly nursing, have risen structurally since the pandemic.
- Very high leverage, which magnifies both good and bad operating outcomes.
Recent developments
- 2026-10-27 · Q3 revenue up 3.6% to $19.85bn and EPS up 4.5% to $7.27, though more uninsured patients cut pretax income by about $400m; 2026 seen in upper half of guidance source
Revenue by segment
| Inpatient Services | 45% |
| Outpatient Services | 40% |
| Other Revenue | 15% |
Five-year forecast
| Revenue | Free cash flow | |
|---|---|---|
| Year 1 | $80.1B | $8.2B |
| Year 2 | $84.8B | $9.1B |
| Year 3 | $89.7B | $10.0B |
| Year 4 | $94.9B | $11.0B |
| Year 5 | $100.4B | $12.1B |
What the street says
Regarded as the best-run hospital operator. Payer mix and policy changes to insurance subsidies drive the debate.
Comparable companies: CVS · CI · TAK · IQV · GEHC · BSX · ELV · TEVA
Open the interactive model, price chart and sensitivity grid →